
Zealand and OTR enter strategic collaboration on metabolic therapies
Zealand Pharma and OTR Therapeutics have entered a multi-programme strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases. The collaboration will combine Zealand Pharma’s experience in obesity and metabolic health with OTR Therapeutics’ oral small-molecule platform. "The multi-programme collaboration will expand our metabolic health pipeline into oral… Read More

